Media stories about Motif Bio (NASDAQ:MTFB) have been trending somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Motif Bio earned a daily sentiment score of 0.19 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 44.9751784763003 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

A number of research firms recently issued reports on MTFB. HC Wainwright set a $32.00 price target on Motif Bio and gave the stock a “buy” rating in a research note on Wednesday, October 11th. WBB Securities began coverage on Motif Bio in a research note on Friday, December 29th. They set a “sell” rating and a $7.00 price target on the stock. Finally, Seaport Global Securities restated a “buy” rating on shares of Motif Bio in a research note on Friday, December 22nd.

Motif Bio (NASDAQ MTFB) opened at $10.80 on Tuesday. Motif Bio has a 12 month low of $5.36 and a 12 month high of $13.75.

ILLEGAL ACTIVITY WARNING: This piece of content was published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of US & international copyright & trademark laws. The correct version of this piece of content can be viewed at

Insider Buying and Selling by Quarter for Motif Bio (NASDAQ:MTFB)

Receive News & Ratings for Motif Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motif Bio and related companies with's FREE daily email newsletter.